These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 32415301)
1. Severe Necrotising Toxoplasmic Retinochoroiditis in a Patient With Crohn's Disease in Use of Adalimumab and Azathioprine. Biancardi AL; Costa JB; de Azevedo LGB; de Moraes HV; Barroso PF; Zaltman C Inflamm Bowel Dis; 2020 Jun; 26(7):e69-e70. PubMed ID: 32415301 [No Abstract] [Full Text] [Related]
2. A case of molluscum contagiosum infection in a patient with Crohn's disease, receiving combination therapy with azathioprine and adalimumab. Cintolo M; Guarneri C; Lentini M J Crohns Colitis; 2015 Jul; 9(7):593-4. PubMed ID: 25908722 [No Abstract] [Full Text] [Related]
3. Ocular Toxoplasmosis Reactivation in a Patient With Inflammatory Bowel Disease Under Treatment With Azathioprine. Puga M; Carpio D; Sampil M; Zamora MJ; Fernandez-Salgado E J Clin Gastroenterol; 2016 Aug; 50(7):610. PubMed ID: 27031813 [No Abstract] [Full Text] [Related]
4. [Severe lymphopenia in a patient with Crohn's disease]. Monasterio C; Kreisel W; Hasselblatt P Internist (Berl); 2018 Aug; 59(8):857-860. PubMed ID: 29356833 [TBL] [Abstract][Full Text] [Related]
5. A Case of Disseminated Tuberculosis in a Child with Crohn's Disease After Treatment with Azathioprine, Adalimumab and Ustekinumab. Renoux MC; Dutronc S; Kollen L; Theret S; Moreau J Arch Bronconeumol; 2021 Aug; 57(8):552-554. PubMed ID: 35699039 [No Abstract] [Full Text] [Related]
6. Guillain-Barré syndrome in association with antitumour necrosis factor therapy: a case of mistaken identity. Patwala K; Crump N; De Cruz P BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28679512 [TBL] [Abstract][Full Text] [Related]
7. Activation of toxoplasma retinochoroiditis during pregnancy and evaluation of ocular findings in newborns. Türkcü FM; Şahin A; Yüksel H; Çınar Y; Cingü K; Altındağ S; Deveci Ö; Özkurt Z; Çaça İ Int Ophthalmol; 2017 Jun; 37(3):559-563. PubMed ID: 27480335 [TBL] [Abstract][Full Text] [Related]
8. Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study]. Hisamatsu T; Matsumoto T; Watanabe K; Nakase H; Motoya S; Yoshimura N; Ishida T; Kato S; Nakagawa T; Esaki M; Nagahori M; Matsui T; Naito Y; Kanai T; Suzuki Y; Nojima M; Watanabe M; Hibi T; J Crohns Colitis; 2019 Sep; 13(9):1097-1104. PubMed ID: 30753377 [TBL] [Abstract][Full Text] [Related]
9. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course. Harris RE; Aloi M; de Ridder L; Croft NM; Koletzko S; Levine A; Turner D; Veereman G; Neyt M; Bigot L; Ruemmele FM; Russell RK; BMJ Open; 2020 Jul; 10(7):e034892. PubMed ID: 32611737 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783 [TBL] [Abstract][Full Text] [Related]
11. Hypersensitivity to azathioprine in a patient with Crohn's disease: a case report. Sousa M; Proença L; Carvalho J Rev Esp Enferm Dig; 2017 Oct; 109(10):735. PubMed ID: 28929775 [TBL] [Abstract][Full Text] [Related]
12. Successful desensitization for azathioprine skin rash in a patient with severe Crohn's disease. Lavaud F; Abdelli N; Thiefin G Dig Dis Sci; 1997 Apr; 42(4):823. PubMed ID: 9125656 [No Abstract] [Full Text] [Related]
13. Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: case report and review of the literature. Vilas-Boas F; Magro F; Balhau R; Lopes JM; Beça F; Eloy C; Lopes S; Macedo G J Crohns Colitis; 2012 Aug; 6(7):792-5. PubMed ID: 22464812 [TBL] [Abstract][Full Text] [Related]
14. Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2). Hisamatsu T; Kato S; Kunisaki R; Matsuura M; Nagahori M; Motoya S; Esaki M; Fukata N; Inoue S; Sugaya T; Sakuraba H; Hirai F; Watanabe K; Kanai T; Naganuma M; Nakase H; Suzuki Y; Watanabe M; Hibi T; Nojima M; Matsumoto T; J Gastroenterol; 2019 Oct; 54(10):860-870. PubMed ID: 31041545 [TBL] [Abstract][Full Text] [Related]
15. Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial. Matsumoto T; Motoya S; Watanabe K; Hisamatsu T; Nakase H; Yoshimura N; Ishida T; Kato S; Nakagawa T; Esaki M; Nagahori M; Matsui T; Naito Y; Kanai T; Suzuki Y; Nojima M; Watanabe M; Hibi T; J Crohns Colitis; 2016 Nov; 10(11):1259-1266. PubMed ID: 27566367 [TBL] [Abstract][Full Text] [Related]
16. [Azathioprine in chronic inflammatory bowel diseases. Evidence base]. Herrlinger K; Stange EF Med Klin (Munich); 2000 Apr; 95(4):201-6. PubMed ID: 10808301 [TBL] [Abstract][Full Text] [Related]
17. [Fatal infectious mononucleosis during azathioprine treatment in Crohn's disease]. Garrido Serrano A; Pérez Martín F; Guerrero Igea FJ; Galbarro Muñoz J; Palomo Gil S Gastroenterol Hepatol; 2000 Jan; 23(1):7-8. PubMed ID: 10726375 [TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis. Hazlewood GS; Rezaie A; Borman M; Panaccione R; Ghosh S; Seow CH; Kuenzig E; Tomlinson G; Siegel CA; Melmed GY; Kaplan GG Gastroenterology; 2015 Feb; 148(2):344-54.e5; quiz e14-5. PubMed ID: 25448924 [TBL] [Abstract][Full Text] [Related]